MAEHARA Takashi¹, KANEKO Naoki², MUNEMURA Ryusuke¹, NAKAMURA Seiji¹ (1.Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu Univ., Fukuoka, Japan, 2.Harvard Univ. (Ragon Institute of MGH, MIT and Harvard), Biston, Massachusetts, USA)

MATSUBARA Ryota^1,2,3, KUMAGAI Kenichi^2,3, NAKASONE Yasunari⁴, EGUCHI Takanori^2,3, SHIGEMATSU Hiroaki^3,5, HOJYO Hideki^2,3, YOSHIZAWA Takamasa^2,3, IMAMURA Eisaku², HAMAD (1.Dept. of OMS, Yokohama General Hospital, Yokohama, Japan, 2.Dept. of OMS, School of Dental Medicine, Tsurumi Univ., Yokohama, Japan, 3.Dept. of Rheumatology and Clinical Immunology, Clinical Research Center for Rheumatology and Allergy, Sagamihara National Hospital, National Hospital Organization, Sagamihara, Japan, 4.Dept. of OMS, Nagano Matsushiro General Hospital, Nagano, Japan, 5.Dept. of OMS, Toshiba Rinkan Hospital, Sagamihara, Japan)

CHOI So-Young¹, HONG Su-Hyung², KANG Soo Hyun², OH Su Young², LEE Heon-Jin², GUM Sangil³, KWON Tae-Geon¹, KIM Jin-Wook¹, LEE Sung-Tak¹ (1.Dept. of OMS, School of Dentistry, Kyungpook National Univ., 2.Dept. of Microbiology and Immunology, School of Dentistry, Kyungpook National Univ., 3.Binaree Co.)

CHEONG Jieun, PARK Kyeong-Mee, PARK Wonse, KIM Kee-Deog (Dept. of Advanced General Dentistry, College of Dentistry, Yonsei Univ., Seoul, Republic of Korea)